{"id":"tocofersolan","rwe":[],"tags":[],"safety":{"commonSideEffects":[{"effect":"Allergic sensitization","drugRate":"reported","severity":"unknown"},{"effect":"Fatigue","drugRate":"reported","severity":"unknown"}]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T17:03:26.845549","allNames":"vedrop","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Alpha-tocopherol transfer protein, Glutathione S-transferase P","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T00:37:10.006Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"indications":{"approved":[{"name":"Obstruction of bile duct","diseaseId":"obstruction-of-bile-duct","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vitamin E deficiency","diseaseId":"vitamin-e-deficiency","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["sideEffects","modality→Small Molecule"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01457690","phase":"PHASE3","title":"Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2011-10","conditions":"Hypobetalipoproteinemias","enrollment":14},{"nctId":"NCT05434260","phase":"NA","title":"Surgiphor vs Saline Joints","status":"UNKNOWN","sponsor":"Center for Innovation and Research Organization","startDate":"2022-09-19","conditions":"Prosthetic-joint Infection","enrollment":868},{"nctId":"NCT05738733","phase":"NA","title":"A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects","status":"COMPLETED","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2023-03-02","conditions":"Healthy Females","enrollment":138},{"nctId":"NCT05429229","phase":"PHASE2","title":"Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Adolfo Daniel Rodriguez-Carrizalez","startDate":"2021-11-01","conditions":"Dry Eye Syndromes, Diabetic Retinopathy, Oxidative Stress","enrollment":78},{"nctId":"NCT05019768","phase":"NA","title":"Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS","status":"COMPLETED","sponsor":"Ciro Caruso","startDate":"2017-09-01","conditions":"Keratoconus","enrollment":41},{"nctId":"NCT04485533","phase":"NA","title":"Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED","status":"UNKNOWN","sponsor":"VISUfarma SpA","startDate":"2020-07-06","conditions":"Dry Eye Syndromes","enrollment":90},{"nctId":"NCT03582384","phase":"PHASE2","title":"Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2020-12","conditions":"Short Bowel Syndrome, Vitamin E Deficiency","enrollment":""},{"nctId":"NCT02322749","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-02","conditions":"Healthy Volunteers Bioequivalence or Bioavailability Study","enrollment":48},{"nctId":"NCT02387580","phase":"PHASE1","title":"Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2015-04","conditions":"Malaria","enrollment":48},{"nctId":"NCT01958619","phase":"PHASE1","title":"Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2013-10","conditions":"Malaria","enrollment":55},{"nctId":"NCT01463735","phase":"PHASE2","title":"Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2011-11","conditions":"Cirrhosis","enrollment":27},{"nctId":"NCT00006047","phase":"PHASE1","title":"Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2000-06","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":44}],"_emaApprovals":[],"_faersSignals":[{"count":7,"reaction":"DRUG INEFFECTIVE"},{"count":7,"reaction":"FATIGUE"},{"count":5,"reaction":"ASTHENIA"},{"count":5,"reaction":"OFF LABEL USE"},{"count":4,"reaction":"ARTHRALGIA"},{"count":4,"reaction":"CONFUSIONAL STATE"},{"count":4,"reaction":"DIARRHOEA"},{"count":3,"reaction":"ALOPECIA"},{"count":3,"reaction":"ANXIETY"},{"count":3,"reaction":"COVID-19"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"approved","brandName":"Vedrop","genericName":"TOCOFERSOLAN","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"2009","aiSummary":"Vedrop, also known as tocofersolan, is a small molecule drug that targets glutathione S-transferase P. It is used to treat obstruction of bile duct and vitamin E deficiency. The commercial status of Vedrop is currently unknown, and it is not clear if it is patented or available as a generic. Vedrop's safety considerations are also not well-documented. Further research is needed to fully understand its pharmacological properties and clinical applications.","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"AU","regulator":"TGA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"CH","regulator":"Swissmedic","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"NO","regulator":"NoMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"IS","regulator":"IMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"NZ","regulator":"Medsafe","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"AT","regulator":"AGES","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"BE","regulator":"FAMHP","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"EU","regulator":"EMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":"EMEA/H/C/000920"},{"country_code":"GB","regulator":"MHRA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"BG","regulator":"BDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"HR","regulator":"HALMED","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"CY","regulator":"PHS","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"CZ","regulator":"SUKL","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"DK","regulator":"DKMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"EE","regulator":"SAM","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"FI","regulator":"Fimea","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"FR","regulator":"ANSM","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"DE","regulator":"BfArM","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"GR","regulator":"EOF","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"HU","regulator":"OGYEI","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"IE","regulator":"HPRA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"IT","regulator":"AIFA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"LV","regulator":"ZVA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"LT","regulator":"VVKT","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"LU","regulator":"MS","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"MT","regulator":"MMA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"NL","regulator":"MEB","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"PL","regulator":"URPL","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"PT","regulator":"Infarmed","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"RO","regulator":"ANMDMR","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"SK","regulator":"SIDC","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"SI","regulator":"JAZMP","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"ES","regulator":"AEMPS","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"SE","regulator":"MPA","status":"approved","approval_date":null,"mah":null,"brand_name_local":"Vedrop","application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}